Evidence map›Paper›PMID 28732070›Full record

ArticlePloS one2017

Characterization of human enterovirus71 virus-like particles used for vaccine antigens.

Dandan Zhao, Bo Sun, Shiyang Sun, Bin Fu, Chuntian Liu, Dawei Liu, Yanfei Chu, Youlei Ma, Lu Bai, Yongge Wu and 7 more

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dandan ZhaoNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Bo SunNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Shiyang SunNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Bin FuBeijing Proteome Research Center, Beijing, China.
Chuntian LiuNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Dawei LiuChangchun BCHT Biotechnology Company, Changchun, China.
Yanfei ChuChangchun BCHT Biotechnology Company, Changchun, China.
Youlei MaChangchun BCHT Biotechnology Company, Changchun, China.
Lu BaiChangchun BCHT Biotechnology Company, Changchun, China.
Yongge WuNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Yan ZhouNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Weiheng SuNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Ali HouNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Linjun CaiNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Fei XuNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Wei KongNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
Chunlai JiangNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.ORCID http://orcid.org/0000-0003-0464-7226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human enterovirus 71 (EV71) is a major causative pathogen of hand, foot and mouth disease (HFMD) and has caused outbreaks with significant mortality among young children in the Asia-Pacific region in recent years. Towards developing a vaccine for this disease, we have expressed and purified EV71 virus-like particles (VLPs), which resemble the authentic virus in appearance, capsid structure and protein sequence, from insect cells (Sf9) using a multistep chromatography process. We demonstrated intracellular localization of the VLPs in host cells by in situ immunogold detection, electron microscopy and immunofluorescence. Characteristics of these EV71 VLPs were studied using a variety of immunological and physicochemical techniques, which aimed to reveal that the purified EV71 VLPs have good morphology and structure consistent with natural EV71 empty capsids. Results of the amino acid analysis, SDS-PAGE, Western blotting and high-performance liquid chromatography confirmed the high purity of the EV71 VLPs. However the sedimentation coefficient of the VLPs showed that they were smaller than that of secreted EV71 VLPs purified by discontinuous cesium chloride density gradients, they were similar to the empty capsids of natural EV71 virions reported previously. Combined with the previous study that EV71 VLPs purified by a multistep chromatography process were able to elicit strong humoral immune responses in mice, our results further supported the conclusion that our EV71 VLPs had well-preserved molecular and structural characteristics. The EV71 VLPs produced from the baculovirus expression system and purified by a multistep chromatography process displayed key structural and immunological features, which would contribute to their efficacy as a HFMD vaccine.

Indexed as

Amino Acid SequenceAnimalsBlotting, WesternChromatography, High Pressure LiquidDynamic Light ScatteringElectrophoresis, Polyacrylamide GelEnterovirus A, HumanImmunohistochemistryMass SpectrometryMicroscopy, Atomic ForceMicroscopy, ConfocalMicroscopy, Electron, TransmissionSf9 CellsVaccines, Virus-Like ParticleViral VaccinesVaccines, Virus-Like ParticleViral Vaccines

Identifiers

PMID28732070
PMCPMC5521781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.